Intraocular Tissue Plasminogen Activator in a Rabbit Model of Traumatic Hyphema

Gene R. Howard, John Vukich, Richard G. Fiscella, Marilyn D. Farber, Morton F Goldberg

Research output: Contribution to journalArticle

Abstract

Tissue plasminogen activator was used to evaluate the clearance of traumatic hyphema in a rabbit model. A neodymium-YAG laser was used to disrupt iris vessels, creating a traumatic hyphema. Tissue plasminogen activator (1800 IU/0.1 mL) was injected into the anterior chamber 24 hours after creation of the hyphema. Two control groups (one receiving balanced salt solution and one receiving no treatment) were used for comparison. A multivariate analysis of covariance indicated that the greatest difference in hyphema clearance between the groups occurred at days 3, 4, and 5. Five days after tissue plasminogen activator treatment, the mean size of the clot remaining in the anterior chamber was 27% of that of the original hyphema. In control eyes, almost 60% of the original clot remained at day 5. Treatment of animals with tissue plasminogen activator doses of 5000 IU and 10 000 IU produced a substantial increase in repeated bleeding episodes in our rabbit model. We concluded that although the use of tissue plasminogen activator in our rabbit model of traumatic hyphema significantly improved clearance of blood from the anterior chamber, the remaining clot was of such size that the clinical benefit was questionable.

Original languageEnglish (US)
Pages (from-to)272-274
Number of pages3
JournalArchives of Ophthalmology
Volume109
Issue number2
DOIs
StatePublished - 1991

Fingerprint

Hyphema
Tissue Plasminogen Activator
Rabbits
Anterior Chamber
Neodymium
Solid-State Lasers
Iris
Multivariate Analysis
Salts
Hemorrhage
Control Groups

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Intraocular Tissue Plasminogen Activator in a Rabbit Model of Traumatic Hyphema. / Howard, Gene R.; Vukich, John; Fiscella, Richard G.; Farber, Marilyn D.; Goldberg, Morton F.

In: Archives of Ophthalmology, Vol. 109, No. 2, 1991, p. 272-274.

Research output: Contribution to journalArticle

Howard, Gene R. ; Vukich, John ; Fiscella, Richard G. ; Farber, Marilyn D. ; Goldberg, Morton F. / Intraocular Tissue Plasminogen Activator in a Rabbit Model of Traumatic Hyphema. In: Archives of Ophthalmology. 1991 ; Vol. 109, No. 2. pp. 272-274.
@article{de48f8e6d1c14054a028451f1bdd368e,
title = "Intraocular Tissue Plasminogen Activator in a Rabbit Model of Traumatic Hyphema",
abstract = "Tissue plasminogen activator was used to evaluate the clearance of traumatic hyphema in a rabbit model. A neodymium-YAG laser was used to disrupt iris vessels, creating a traumatic hyphema. Tissue plasminogen activator (1800 IU/0.1 mL) was injected into the anterior chamber 24 hours after creation of the hyphema. Two control groups (one receiving balanced salt solution and one receiving no treatment) were used for comparison. A multivariate analysis of covariance indicated that the greatest difference in hyphema clearance between the groups occurred at days 3, 4, and 5. Five days after tissue plasminogen activator treatment, the mean size of the clot remaining in the anterior chamber was 27{\%} of that of the original hyphema. In control eyes, almost 60{\%} of the original clot remained at day 5. Treatment of animals with tissue plasminogen activator doses of 5000 IU and 10 000 IU produced a substantial increase in repeated bleeding episodes in our rabbit model. We concluded that although the use of tissue plasminogen activator in our rabbit model of traumatic hyphema significantly improved clearance of blood from the anterior chamber, the remaining clot was of such size that the clinical benefit was questionable.",
author = "Howard, {Gene R.} and John Vukich and Fiscella, {Richard G.} and Farber, {Marilyn D.} and Goldberg, {Morton F}",
year = "1991",
doi = "10.1001/archopht.1991.01080020118055",
language = "English (US)",
volume = "109",
pages = "272--274",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Intraocular Tissue Plasminogen Activator in a Rabbit Model of Traumatic Hyphema

AU - Howard, Gene R.

AU - Vukich, John

AU - Fiscella, Richard G.

AU - Farber, Marilyn D.

AU - Goldberg, Morton F

PY - 1991

Y1 - 1991

N2 - Tissue plasminogen activator was used to evaluate the clearance of traumatic hyphema in a rabbit model. A neodymium-YAG laser was used to disrupt iris vessels, creating a traumatic hyphema. Tissue plasminogen activator (1800 IU/0.1 mL) was injected into the anterior chamber 24 hours after creation of the hyphema. Two control groups (one receiving balanced salt solution and one receiving no treatment) were used for comparison. A multivariate analysis of covariance indicated that the greatest difference in hyphema clearance between the groups occurred at days 3, 4, and 5. Five days after tissue plasminogen activator treatment, the mean size of the clot remaining in the anterior chamber was 27% of that of the original hyphema. In control eyes, almost 60% of the original clot remained at day 5. Treatment of animals with tissue plasminogen activator doses of 5000 IU and 10 000 IU produced a substantial increase in repeated bleeding episodes in our rabbit model. We concluded that although the use of tissue plasminogen activator in our rabbit model of traumatic hyphema significantly improved clearance of blood from the anterior chamber, the remaining clot was of such size that the clinical benefit was questionable.

AB - Tissue plasminogen activator was used to evaluate the clearance of traumatic hyphema in a rabbit model. A neodymium-YAG laser was used to disrupt iris vessels, creating a traumatic hyphema. Tissue plasminogen activator (1800 IU/0.1 mL) was injected into the anterior chamber 24 hours after creation of the hyphema. Two control groups (one receiving balanced salt solution and one receiving no treatment) were used for comparison. A multivariate analysis of covariance indicated that the greatest difference in hyphema clearance between the groups occurred at days 3, 4, and 5. Five days after tissue plasminogen activator treatment, the mean size of the clot remaining in the anterior chamber was 27% of that of the original hyphema. In control eyes, almost 60% of the original clot remained at day 5. Treatment of animals with tissue plasminogen activator doses of 5000 IU and 10 000 IU produced a substantial increase in repeated bleeding episodes in our rabbit model. We concluded that although the use of tissue plasminogen activator in our rabbit model of traumatic hyphema significantly improved clearance of blood from the anterior chamber, the remaining clot was of such size that the clinical benefit was questionable.

UR - http://www.scopus.com/inward/record.url?scp=0026022998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026022998&partnerID=8YFLogxK

U2 - 10.1001/archopht.1991.01080020118055

DO - 10.1001/archopht.1991.01080020118055

M3 - Article

C2 - 1899562

AN - SCOPUS:0026022998

VL - 109

SP - 272

EP - 274

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 2

ER -